Clinical & Translational Investigators in Skin Cancer

Overview

Our research portfolio consists of clinical and translational research projects in skin cancer. The Miller Lab’s long-term goal is to identify and develop novel therapeutics for advanced skin cancer and to understand the mechanism of response and resistance to those therapies. Dr. Miller is the principal investigator of several clinical trials in Merkel Cell Carcinoma and Cutaneous Squamous Cell Carcinoma at the Mass General Cancer Center. These studies are evaluating new treatment approaches in the neoadjuvant, adjuvant and refractory disease setting. In order to complement our clinical trial efforts, our lab is developing clinical informatic platforms to optimize real world data collection.